Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cencora Inc (NY: COR )

245.91 +0.22 (+0.09%)
Streaming Delayed Price Updated: 11:44 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 252,093
Open 246.12
Bid (Size) 245.81 (8)
Ask (Size) 245.99 (8)
Prev. Close 245.69
Today's Range 245.20 - 247.55
52wk Range 195.83 - 251.56
Shares Outstanding 44,197,721
Dividend Yield 0.83%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Looking Into Cencora's Recent Short Interest
Via Benzinga
McKesson Stock Gets A RS Rating Lift To 75
The Relative Strength (RS) Rating for McKesson stock jumped into a new percentile Wednesday, as it got a lift from 70 to 75. 
Via Investor's Business Daily

Performance

YTD
+17.92%
+17.92%
1 Month
+5.02%
+5.02%
3 Month
+2.21%
+2.21%
6 Month
+11.87%
+11.87%
1 Year
+23.15%
+23.15%

More News

Read More
Cardinal Health Stock Sees IBD RS Rating Improve To 71
Via Investor's Business Daily
Deep Dive Into Cencora Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
Trump's Win Sends Indices To Record Highs; Financials, Small Caps Surge, Bitcoin Tops $75,000: What's Driving Markets Wednesday?
Via Benzinga
Topics Government
Exposures Political
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,700 Today
Via Benzinga
Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings
Via Benzinga
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
From Cencora
Via Business Wire
Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
From Cencora
Via Business Wire
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
From Cencora
Via Business Wire
Analyst Scoreboard: 6 Ratings For Cencora
Via Benzinga
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today
Via Benzinga
Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years
Via Benzinga
Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy
Via MarketBeat
Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
From Cencora
Via Business Wire
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
Via Benzinga
Deep Dive Into Cencora Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
$1000 Invested In Cencora 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Deep Dive Into Cencora Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
Why Walgreens Boots Alliance Fell Another 22% in August
Via The Motley Fool
Is the Temu Hype Warranted?
Via The Motley Fool
Opioid Settlement: Drug Distributors McKesson, Cencora, Cardinal Health To Pay $300M To Health Insurers
Via Benzinga
Is Cash Flow a Problem for Walgreens Boots Alliance?
Via The Motley Fool
Cencora Elects Frank Clyburn to Its Board of Directors
From Cencora
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.